519 results on '"Denis, Cécile V."'
Search Results
2. A small-molecule hemostatic agent for the reversal of direct oral anticoagulant–induced bleeding
3. Impact of allele-selective silencing of von Willebrand factor in mice based on a single nucleotide allelic difference in von Willebrand factor
4. Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor
5. Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs
6. How unique structural adaptations support and coordinate the complex function of von Willebrand factor
7. Angiopoietin-2 binds to multiple interactive sites within von Willebrand factor
8. Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy
9. Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in von Willebrand disease murine models
10. A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD
11. ADP receptor P2Y12 is the capstone of the cross-talk between Ca2+ mobilization pathways dependent on Ca2+ ATPases sarcoplasmic/endoplasmic reticulum type 3 and type 2b in platelets
12. Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab
13. A gain‐of‐function filamin A mutation in mouse platelets induces thrombus instability
14. Antithrombotic potential of a single‐domain antibody enhancing the activated protein C‐cofactor activity of protein S
15. New insights into regulation of αIIbβ3 integrin signaling by filamin A
16. Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis
17. Camelid‐derived single‐chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications
18. The Role of Platelets and von Willebrand Factor in the Procoagulant Phenotype of Inflammatory Bowel Disease.
19. Development and characterization of single‐domain antibodies neutralizing protease nexin‐1 as tools to increase thrombin generation
20. Measuring beta‐galactose exposure on platelets: Standardization and healthy reference values
21. Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc
22. The role of platelets and von Willebrand factor in the procoagulant phenotype of inflammatory bowel disease
23. MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation
24. Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia
25. A single‐domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor
26. Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia
27. Disrupted filamin A/αIIbβ3 interaction induces macrothrombocytopenia by increasing RhoA activity
28. The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction
29. Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor
30. A mutation of the human EPHB2 gene leads to a major platelet functional defect
31. IdeS, a new option to optimize the management of patients with hemophilia A on emicizumab
32. NAADP/SERCA3-Dependent Ca2+ Stores Pathway Specifically Controls Early Autocrine ADP Secretion Potentiating Platelet Activation
33. Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?
34. Complex formation with pentraxin-2 regulates factor X plasma levels and macrophage interactions
35. Defect in Regulated Secretion of P-Selectin Affects Leukocyte Recruitment in von Willebrand
36. Modèles murins en hémostase.
37. Macrophage receptor SR-AI is crucial to maintain normal plasma levels of coagulation factor X
38. Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice
39. von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends
40. Von Willebrand factor and cancer: Another piece of the puzzle
41. P.31 Von Willebrand Factor Induces Vascular Smooth Muscle Cell Proliferation and Migration Through Low Density Lipoprotein-Related Receptor Protein 4 and αvβ3 Integrin
42. Impact of PI3Kα (Phosphoinositide 3-Kinase Alpha) Inhibition on Hemostasis and Thrombosis
43. Transient von Willebrand factor‐mediated platelet influx stimulates liver regeneration after partial hepatectomy in mice
44. Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B–associated thrombocytopenia
45. N-Glycosylation Deficiency Reduces the Activation of Protein C and Disrupts Endothelial Barrier Integrity
46. Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization
47. Mutations in the A3 domain of Von Willebrand factor inducing combined qualitative and quantitative defects in the protein
48. A Novel Single-Domain Antibody Against von Willebrand Factor A1 Domain Resolves Leukocyte Recruitment and Vascular Leakage During Inflammation—Brief Report
49. Emerging Therapeutic Strategies in the Treatment of Hemophilia A
50. A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.